Having survived a life threatening illness, worked as a primary care provider and facilitator of care transformation with hundreds of primary care providers and hospital systems and authored a book on redesigning primary care, I laud your effort here.
I would like to submit a new technology breakthrough of faster lab testing that requires drops vs. vials of blood at less cost (posted on their website) than Medicaid reimbursement. While there may be other companies providing the technology, currently Theranos (with whom I have no professional or personal relationship) is making inroads in California and Arizona via retail pharmacy testing. They also have contracts with UCSF and several other large healthcare systems.
86,000,000 Americans are pre-diabetic, 90% of whom don’t know they have it. If given ready access to lab information only 5% of these folks improve their diet and lifestyle would this not improve engagement and reduce costs?
Since 70-80% of clinical decision making is based on lab results, lower lab costs make ongoing vs. episodic monitoring to engage with patients and improve health far more viable.
As with other innovations, the activated, engaged 18-20% of patients may initially embrace ongoing access to lab information to better engage with providers and their own health. But, perhaps like the diffusion of ATMs, over time the innovators and early adopters will lead the majority to more active engagement in their own health and care.